With regards to Ellsworth et al. on "Lymphocyte sparing normal tissue effects in the clinic LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy"

Affiliations

¹ Loyola University Chicago, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, IL 60153, USA; Edward Hines Veteran Affairs Hospital, Chicago, IL, USA. Electronic address: bhanuprasad.venkatesulu@luhs.org.
² Department of Radiation Oncology, Tata Memorial Center, Varanasi, India.

Comment

BhanuPrasad Venkatesulu et al. Radiother Oncol. 2023 Apr.

. 2023 Apr:181:109496.

doi: 10.1016/j.radonc.2023.109496. Epub 2023 Feb 2.

¹ Loyola University Chicago, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, IL 60153, USA; Edward Hines Veteran Affairs Hospital, Chicago, IL, USA. Electronic address: bhanuprasad.venkatesulu@luhs.org.
² Department of Radiation Oncology, Tata Memorial Center, Varanasi, India.

No abstract available

Comment on

Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy.
Venkatesulu B, Giridhar P, Pujari L, Chou B, Lee JH, Block AM, Upadhyay R, Welsh JS, Harkenrider MM, Krishnan S, Verma V, En Hsieh C, Pradhan S, Small W Jr, Solanki AA. Venkatesulu B, et al. Radiother Oncol. 2022 Dec;177:81-94. doi: 10.1016/j.radonc.2022.10.019. Epub 2022 Nov 2. Radiother Oncol. 2022. PMID: 36334694
RE: Venkatesulu et al. (Letter to the Editor).
Ellsworth SG, Mohan R, Lin SH. Ellsworth SG, et al. Radiother Oncol. 2023 Apr;181:109490. doi: 10.1016/j.radonc.2023.109490. Epub 2023 Feb 2. Radiother Oncol. 2023. PMID: 36736591 No abstract available.